J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Egalet Reports First Quarter 2017 Financial Results May 9, 2017 Acorda Investor Urges for Company to Explore Sale August 6, 2017 6 Biopharma Companies Face Catalysts in February January 30, 2017
